查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1179503

3D 细胞培养市场：按产品、应用、最终用户分类：2021-2031 年全球机遇分析和行业预测

3D Cell Culture Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 244 Pages | 商品交期: 2-3个工作天内

价格

3D 细胞培养是一种体外技术，可让细胞在人工创造的环境中生长。

这些环境与本地组织的结构和功能非常相似。 3D 细胞培养技术通过与类似于体内的三维环境相互作用，帮助刺激细胞分化、增殖和迁移。 由于 3D 细胞培养可以模拟体内组织的结构、活动和微环境，因此该技术在药物筛选、再生医学、干细胞治疗、癌症研究和细胞生物学方面具有许多潜在应用。 在 3D 培养中，细胞外基质分泌细胞因子和营养因子，并进行直接接触以实现细胞间通讯，类似于体内环境。 二维环境中这些因素的变化会深刻影响细胞间的通讯，导致细胞形态和增殖发生改变。 这种技术在医疗保健研究领域越来越受欢迎，因为 2D 培养物无法再现 3D 培养物的结构和復杂细胞基质。 此外，3D 细胞培养可以提高效率并降低整个研发过程的成本。

3D 细胞培养市场按产品细分为基于支架的平台、无支架平台、凝胶、生物反应器、微芯片和服务。 基于支架的平台用于通过提供一个表面来修改细胞培养程序，细胞可以在该表面上轻鬆地进行 3D 生长。 支架用于药物发现和细胞生长，因为它们有多种材料和结构可供选择。 支架也很容易成像，并具有简单化验协议的优势。 此外，支架的机械和生化特性可以根据应用需要轻鬆修改。 因此，由于对用于创建 3D 细胞培养的基于脚手架的平台的高需求，预计该细分市场将在整个预测期内主导产品细分市场。 然而，基于支架的平台可以通过吸附测试物质、限制下游端点进行分析以及允许引入不同的生物物质来抑製片段生长。

根据应用，3D 细胞培养市场分为癌症研究、干细胞研究、药物发现和再生医学。 癌症研究领域预计将成为分析期内增长最大的领域。 这包括促进细胞生长和改变形态，揭示真实的药物反应，捕捉表型异质性，以及实现基因表达和细胞行为的实验操作。，以代表肿瘤微环境。 利用 3D 细胞培养优势的早期临床前研究可以决定性地提高我们对癌症生物学的理解。 这包括消除较差的候选药物和识别以前在二维培养中无法获得的生理学相关目标。 这可能会显着促进该细分市场的增长。

根据最终用户，全球 3D 细胞培养市场分为生物技术和製药公司、合同研究机构和学术机构。 在整个分析期间，学术机构部门在最终用户领域占据主导地位。 由于各种医疗保健应用对 3D 细胞培养的需求不断增加，这种增长归因于研究机构和临床实验室以及多家公司之间的合作增加。 例如，Procter &Gamble (P&G) 和英国杜伦大学正在合作创建 3D 皮肤替代品，使用模拟组织的 2D 平台来研究体外衰老过程。 此外，许多学术机构将研发活动的重点放在 3D 培养模型上，以开发治疗各种疾病的新方法。 学术机构和大学研究活动的激增预计将在分析期间推动该领域的增长。

在预测期内，北美将继续占据主导地位，因为有几家製药和生物技术公司与研究机构和临床实验室合作使用 3D 培养技术进行再生医学和药物发现开发。预计将保持这一趋势。 此外，器官移植需求的增加以及专注于技术先进解决方案的研发活动的增加预计将推动该地区采用 3D 细胞培养。 此外，癌症发病率的激增导致政府增加了对癌症□□领域研发的资金和补贴，这可能对 3D 细胞培养市场的增长产生积极影响。 此外，生物技术和製药公司的战略扩张推出了先进的产品，预计将在未来几年推动市场增长。

对利益相关者的主要好处

本报告定量分析了 2021 年至 2031 年 3D 细胞培养市场分析的细分市场、当前趋势、估计和动态，以确定 3D 细胞培养市场的主要机会。

市场研究提供了有关关键驱动因素、市场限制和机会的信息。

波特的五力分析强调了买家和供应商在帮助利益相关者做出以利润为导向的商业决策和加强供应商-买家网络方面的潜力。

对 3D 细胞培养市场细分的详细分析有助于确定总体市场机会。

每个地区的主要国家根据其对全球市场的收入贡献进行映射。

市场参与者定位有助于进行基准测试，并提供对市场参与者当前位置的清晰了解。

本报告分析了区域和全球 3D 细胞培养市场趋势、主要参与者、细分市场、应用领域和市场增长战略。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要投资领域
  • 波特的五力分析
  • 主要公司的定位
  • 市场动态
    • 司机
    • 约束因素
    • 机会
  • COVID-19 影响分析

第 4 章 3D 细胞培养市场：按产品分类

  • 概览
    • 市场规模和预测
  • 基于脚手架的平台
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：国家分析
    • 支架平台 3D 细胞培养市场：按宏观分类
    • 支架平台 3D 细胞培养市场：按微型分类
    • 支架平台 3D 细胞培养市场：按纳米级分类
    • 基于支架的 3D 细胞培养平台市场：按固体支架分类
  • 无脚手架平台
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：国家分析
  • 凝胶
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 生物反应器
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 微芯片
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 服务
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 5 章 3D 细胞培养市场：按应用

  • 概览
    • 市场规模和预测
  • 癌症研究
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 干细胞研究
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 药物发现
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 再生医学
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 6 章 3D 细胞培养市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 生物技术公司、製药公司
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 调查机构
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类
  • 学术机构
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场分析：按国家/地区分类

第 7 章 3D 细胞培养市场：按地区

  • 概览
    • 市场规模和预测
  • 北美
    • 主要趋势和机会
    • 北美市场规模和预测：按产品
    • 北美市场规模和预测：按应用
    • 北美市场规模和预测：按最终用户分类
    • 北美市场规模和预测：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 主要趋势和机会
    • 欧洲市场规模和预测：按产品
    • 欧洲市场规模和预测：按应用分类
    • 欧洲市场规模和预测：按最终用户分类
    • 欧洲市场规模和预测：按国家/地区分类
      • 德国
      • 法国
      • 英国
      • 其他欧洲地区
  • 亚太地区
    • 主要趋势和机会
    • 亚太市场规模和预测：按产品
    • 亚太市场规模和预测：按应用
    • 亚太市场规模和预测：按最终用户分类
    • 亚太地区的市场规模和预测：按国家/地区分类
      • 日本
      • 中国
      • 印度
      • 澳大利亚
      • 其他亚太地区
  • 拉美
    • 主要趋势和机会
    • LAMEA 市场规模和预测：按产品
    • LAMEA 市场规模和预测：按应用分类
    • LAMEA 市场规模和预测：按最终用户分类
    • LAMEA 市场规模和预测：按国家/地区分类
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其余部分

第八章公司情况

  • 简介
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 主要发展

第九章公司简介

  • 3d Biotek LLC
  • Advanced Biomatrix, Inc.
  • Avantor, Inc.
  • Becton, Dickinson And Company
  • Corning Incorporated
  • Insphero AG
  • Lonza Group LTD.
  • Merck & Co., Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.
Product Code: A01155

A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture and functioning of the native tissue. 3D cell culture technique helps stimulate cell differentiation, proliferation, and migration by interacting with their three-dimensional surroundings as they would in the in-vivo environment. As 3D cell cultures can mimic the structure, activity, and microenvironment of the in-vivo tissues, this technique has varied applications in the fields of drug screening, regenerative medicine, stem cell therapies, cancer research and cell biology. The extracellular matrix in 3D cell cultures enables cell-cell communication by direct contact as in in-vivo environment by secreting cytokines and trophic factors. These factors are changed in a 2D environment that can significantly affect the cell-cell communication, which in turn can alter the cell morphology and proliferation. As 2D cultures cannot recapitulate the architecture and complex cellular matrices as in 3D cultures, this technique is gaining popularity in healthcare research sector. In addition, 3D cell cultures can provide results with improved efficiency and reduce the cost of overall R&D process. 

Based on product, the 3D cell culture market can be categorized into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips, and services. Scaffold-based platforms are used to alter the cell culture procedure by providing a surface on which the cells can easily impart 3D growth. Scaffolds are used in drug discovery and cell expansion, owing to the availability of a variety of materials and structural choices. In addition, there are other advantages related to the use of scaffold-based platforms such as ease of imaging and simple assay protocol. Moreover, the mechanical and biochemical properties of the scaffold can easily be modified as per the need of the application. Thus, this segment is expected to dominate the product segment throughout the forecast period as there is a high demand for scaffold-based platforms for creating 3D cell cultures. Nevertheless, scaffold-based platforms can adsorb test compounds, limit downstream endpoints for analysis, and introduce different biological substances, thereby obstructing the segment growth.

Based on application, the 3D cell culture market is segmented into cancer research, stem cell research, drug discovery, and regenerative medicine. Cancer research segment is anticipated to be the largest growing segment over the analysis period. This is majorly attributed to the advantages offered by 3D cell culture in cancer research, these include ease of altering cell proliferation and morphology, revealing realistic drug response, capturing phenotypic heterogeneity, allowing experimental manipulation in gene expression & cell behavior and representing the tumor microenvironment. Preclinical studies that utilize the benefits of 3D cell culture early on can critically improvise the understanding of cancer biology. These include elimination of poor drug candidates and identification of physiologically relevant targets that were previously inaccessible in 2D cultures. This can largely contribute toward the segment growth.

Based on end user, the global 3D cell culture market is segmented into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. The academic institutes segment held a dominant position in the end user segment throughout the analysis period. This growth is due to rise in collaborations between several companies with research institutes and clinical laboratories owing to the rise in demand of 3D cell cultures for various healthcare applications. For instance, Procter & Gamble (P&G) and Durham University based in the UK have collaborated for engineering 3D skin substitutes with the help of tissue-mimetic 2D platforms for studying the process of ageing in-vitro. In addition, many academic institutes have focused their R&D activities toward 3D culture models for developing novel approaches for treating different medical conditions. This surge in research activities across academic institutes and universities is predicted to propel the growth of the segment over the analysis period.

North America is expected to maintain its dominance during the forecast period due to the presence of several pharmaceutical and biotechnology companies that use 3D culture technology in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development. Furthermore, rise in demand for organ transplantation and upsurge in R&D activities focused on technologically advanced solutions is predicted to fuel the adoption of 3D cell culture practices in the region. In addition, surge in incidences of cancer has led the government to increase the funding and grants for R&D in the field of cancer, which may have a positive impact on the 3D cell culture market growth. Moreover, the strategic expansion of biotechnological and pharmaceutical companies has led to launch of advanced products, which are expected to augment the market growth in coming years.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the 3d cell culture market analysis from 2021 to 2031 to identify the prevailing 3d cell culture market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the 3d cell culture market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global 3d cell culture market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Scaffold Free Platforms
  • Gels
  • Bioreactors
  • Microchips
  • Services
  • Scaffold Based Platforms
    • Macro-scale
    • Micro-scale
    • Nano-scale
    • Solid Scaffolds

By Application

  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative medicine

By End User

  • Biotechnology and Pharmaceutical Companies
  • Contract Research Laboratories
  • Academic Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Rest of Asia-Pacific
    • Japan
    • China
    • India
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • 3d Biotek LLC
    • Advanced Biomatrix, Inc.
    • Avantor, Inc.
    • Becton, Dickinson And Company
    • Corning Incorporated
    • Insphero AG
    • Lonza Group LTD.
    • Merck & Co., Inc.
    • Synthecon, Incorporated
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: 3D CELL CULTURE MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Scaffold Based Platforms
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Scaffold Based Platforms 3D Cell Culture Market by Macro-scale
    • 4.2.5 Scaffold Based Platforms 3D Cell Culture Market by Micro-scale
    • 4.2.6 Scaffold Based Platforms 3D Cell Culture Market by Nano-scale
    • 4.2.7 Scaffold Based Platforms 3D Cell Culture Market by Solid Scaffolds
  • 4.3 Scaffold Free Platforms
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Gels
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Bioreactors
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Microchips
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country
  • 4.7 Services
    • 4.7.1 Key market trends, growth factors and opportunities
    • 4.7.2 Market size and forecast, by region
    • 4.7.3 Market analysis by country

CHAPTER 5: 3D CELL CULTURE MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Cancer Research
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Stem Cell Research
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Drug Discovery
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Regenerative medicine
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: 3D CELL CULTURE MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Biotechnology and Pharmaceutical Companies
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Contract Research Laboratories
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Academic Institutes
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: 3D CELL CULTURE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Rest of Europe
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3d Biotek LLC
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Advanced Biomatrix, Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Avantor, Inc.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Becton, Dickinson And Company
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Corning Incorporated
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Insphero AG
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Lonza Group LTD.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Merck & Co., Inc.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Synthecon, Incorporated
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Thermo Fisher Scientific Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD BASED PLATFORMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. 3D CELL CULTURE MARKET FOR SCAFFOLD BASED PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MACRO-SCALE, 2021-2031 ($MILLION)
  • TABLE 5. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MICRO-SCALE, 2021-2031 ($MILLION)
  • TABLE 6. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY NANO-SCALE, 2021-2031 ($MILLION)
  • TABLE 7. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY SOLID SCAFFOLDS, 2021-2031 ($MILLION)
  • TABLE 8. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD FREE PLATFORMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. 3D CELL CULTURE MARKET FOR SCAFFOLD FREE PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. 3D CELL CULTURE MARKET SIZE, FOR GELS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. 3D CELL CULTURE MARKET FOR GELS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. 3D CELL CULTURE MARKET SIZE, FOR BIOREACTORS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. 3D CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. 3D CELL CULTURE MARKET SIZE, FOR MICROCHIPS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. 3D CELL CULTURE MARKET FOR MICROCHIPS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. 3D CELL CULTURE MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. 3D CELL CULTURE MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 19. 3D CELL CULTURE MARKET SIZE, FOR CANCER RESEARCH, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. 3D CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. 3D CELL CULTURE MARKET SIZE, FOR STEM CELL RESEARCH, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. 3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. 3D CELL CULTURE MARKET SIZE, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. 3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. 3D CELL CULTURE MARKET SIZE, FOR REGENERATIVE MEDICINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. 3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. GLOBAL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 28. 3D CELL CULTURE MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 29. 3D CELL CULTURE MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. 3D CELL CULTURE MARKET SIZE, FOR CONTRACT RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 31. 3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. 3D CELL CULTURE MARKET SIZE, FOR ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 33. 3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 34. 3D CELL CULTURE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 35. NORTH AMERICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 36. NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 37. NORTH AMERICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 39. U.S. 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 40. U.S. 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. U.S. 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. CANADA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 43. CANADA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. CANADA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. MEXICO 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 46. MEXICO 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. MEXICO 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 49. EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 50. EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. EUROPE 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 52. GERMANY 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 53. GERMANY 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 54. GERMANY 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. FRANCE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. FRANCE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. FRANCE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. UK 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 59. UK 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. UK 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 71. CHINA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 72. CHINA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 73. CHINA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. INDIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 75. INDIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. INDIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 80. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 81. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 84. LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 85. LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 86. LAMEA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 87. BRAZIL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 88. BRAZIL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 89. BRAZIL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 90. SAUDI ARABIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 91. SAUDI ARABIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. SAUDI ARABIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. SOUTH AFRICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 94. SOUTH AFRICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 95. SOUTH AFRICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 96. REST OF LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 97. REST OF LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 98. REST OF LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99.3D BIOTEK LLC: COMPANY SNAPSHOT
  • TABLE 100.3D BIOTEK LLC: OPERATING SEGMENTS
  • TABLE 101.3D BIOTEK LLC: PRODUCT PORTFOLIO
  • TABLE 102.3D BIOTEK LLC: NET SALES,
  • TABLE 103.3D BIOTEK LLC: KEY STRATERGIES
  • TABLE 104.ADVANCED BIOMATRIX, INC.: COMPANY SNAPSHOT
  • TABLE 105.ADVANCED BIOMATRIX, INC.: OPERATING SEGMENTS
  • TABLE 106.ADVANCED BIOMATRIX, INC.: PRODUCT PORTFOLIO
  • TABLE 107.ADVANCED BIOMATRIX, INC.: NET SALES,
  • TABLE 108.ADVANCED BIOMATRIX, INC.: KEY STRATERGIES
  • TABLE 109.AVANTOR, INC.: COMPANY SNAPSHOT
  • TABLE 110.AVANTOR, INC.: OPERATING SEGMENTS
  • TABLE 111.AVANTOR, INC.: PRODUCT PORTFOLIO
  • TABLE 112.AVANTOR, INC.: NET SALES,
  • TABLE 113.AVANTOR, INC.: KEY STRATERGIES
  • TABLE 114.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 115.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 116.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 117.BECTON, DICKINSON AND COMPANY: NET SALES,
  • TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 119.CORNING INCORPORATED: COMPANY SNAPSHOT
  • TABLE 120.CORNING INCORPORATED: OPERATING SEGMENTS
  • TABLE 121.CORNING INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 122.CORNING INCORPORATED: NET SALES,
  • TABLE 123.CORNING INCORPORATED: KEY STRATERGIES
  • TABLE 124.INSPHERO AG: COMPANY SNAPSHOT
  • TABLE 125.INSPHERO AG: OPERATING SEGMENTS
  • TABLE 126.INSPHERO AG: PRODUCT PORTFOLIO
  • TABLE 127.INSPHERO AG: NET SALES,
  • TABLE 128.INSPHERO AG: KEY STRATERGIES
  • TABLE 129.LONZA GROUP LTD.: COMPANY SNAPSHOT
  • TABLE 130.LONZA GROUP LTD.: OPERATING SEGMENTS
  • TABLE 131.LONZA GROUP LTD.: PRODUCT PORTFOLIO
  • TABLE 132.LONZA GROUP LTD.: NET SALES,
  • TABLE 133.LONZA GROUP LTD.: KEY STRATERGIES
  • TABLE 134.MERCK & CO., INC.: COMPANY SNAPSHOT
  • TABLE 135.MERCK & CO., INC.: OPERATING SEGMENTS
  • TABLE 136.MERCK & CO., INC.: PRODUCT PORTFOLIO
  • TABLE 137.MERCK & CO., INC.: NET SALES,
  • TABLE 138.MERCK & CO., INC.: KEY STRATERGIES
  • TABLE 139.SYNTHECON, INCORPORATED: COMPANY SNAPSHOT
  • TABLE 140.SYNTHECON, INCORPORATED: OPERATING SEGMENTS
  • TABLE 141.SYNTHECON, INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 142.SYNTHECON, INCORPORATED: NET SALES,
  • TABLE 143.SYNTHECON, INCORPORATED: KEY STRATERGIES
  • TABLE 144.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 145.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 146.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 147.THERMO FISHER SCIENTIFIC INC.: NET SALES,
  • TABLE 148.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.3D CELL CULTURE MARKET SEGMENTATION
  • FIGURE 2.3D CELL CULTURE MARKET,2021-2031
  • FIGURE 3.3D CELL CULTURE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.3D CELL CULTURE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.3D CELL CULTURE MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SCAFFOLD FREE PLATFORMS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GELS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BIOREACTORS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MICROCHIPS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SERVICES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 19.3D CELL CULTURE MARKET,BY APPLICATION,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CANCER RESEARCH 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF STEM CELL RESEARCH 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF REGENERATIVE MEDICINE 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 24.3D CELL CULTURE MARKET,BY END USER,2021(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF CONTRACT RESEARCH LABORATORIES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF ACADEMIC INSTITUTES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 28.3D CELL CULTURE MARKET BY REGION,2021
  • FIGURE 29.U.S. 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 30.CANADA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 31.MEXICO 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 32.GERMANY 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 33.FRANCE 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 34.UK 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 37.CHINA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 38.INDIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 39.AUSTRALIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 41.BRAZIL 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 42.SAUDI ARABIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH AFRICA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF LAMEA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 51.3D BIOTEK LLC.: NET SALES ,($MILLION)
  • FIGURE 52.ADVANCED BIOMATRIX, INC..: NET SALES ,($MILLION)
  • FIGURE 53.AVANTOR, INC..: NET SALES ,($MILLION)
  • FIGURE 54.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
  • FIGURE 55.CORNING INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 56.INSPHERO AG.: NET SALES ,($MILLION)
  • FIGURE 57.LONZA GROUP LTD..: NET SALES ,($MILLION)
  • FIGURE 58.MERCK & CO., INC..: NET SALES ,($MILLION)
  • FIGURE 59.SYNTHECON, INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 60.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)